Effectiveness and Safety of Firmagon in Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma in the Netherlands.
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2015
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms FAST-NL
- 18 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Nov 2014 Planned End Date changed from 1 Dec 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 16 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.